SCM
GSK icon

Sterling Capital Management’s GSK GSK Stock Holding History

Sterling Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,771
Closed -$940K – 3245
2025
Q3 		$940K Sell
21,771
-2,989
-12% -$117K 0.01% 648
2025
Q2 		$951K Sell
24,760
-578
-2% -$22.1K 0.01% 649
2025
Q1 		$982K Buy
25,338
+1,789
+8% +$65.5K 0.02% 619
2024
Q4 		$796K Buy
23,549
+2,113
+10% +$76.1K 0.01% 705
2024
Q3 		$876K Buy
+21,436
New +$877K 0.01% 637
2019
Q3 		$377K Hold
7,062
– – ﹤0.01% 782
2019
Q2 		$353K Sell
7,062
-188
-3% -$9.43K ﹤0.01% 786
2019
Q1 		$379K Sell
7,250
-1,734
-19% -$86.6K ﹤0.01% 767
2018
Q4 		$429K Sell
8,984
-825
-8% -$40.6K ﹤0.01% 766
2018
Q3 		$493K Sell
9,809
-643
-6% -$32.7K ﹤0.01% 787
2018
Q2 		$527K Sell
10,452
-2,796
-21% -$141K ﹤0.01% 753
2018
Q1 		$647K Buy
13,248
+1,281
+11% +$59.7K 0.01% 730
2017
Q4 		$531K Buy
11,967
+1,919
+19% +$88.7K ﹤0.01% 763
2017
Q3 		$510K Buy
10,048
+3,170
+46% +$161K ﹤0.01% 768
2017
Q2 		$371K Sell
6,878
-305
-4% -$16.3K ﹤0.01% 806
2017
Q1 		$379K Buy
7,183
+25
+0.3% +$1.27K ﹤0.01% 821
2016
Q4 		$345K Sell
7,158
-569
-7% -$28.1K ﹤0.01% 826
2016
Q3 		$417K Buy
7,727
+272
+4% +$14.9K ﹤0.01% 769
2016
Q2 		$404K Buy
7,455
+873
+13% +$46K ﹤0.01% 783
2016
Q1 		$334K Buy
6,582
+55
+0.8% +$2.74K ﹤0.01% 805
2015
Q4 		$329K Sell
6,527
-42
-0.6% -$2.14K ﹤0.01% 849
2015
Q3 		$316K Buy
6,569
+331
+5% +$17.2K ﹤0.01% 857
2015
Q2 		$325K Buy
6,238
+681
+12% +$38.3K ﹤0.01% 783
2015
Q1 		$321K Buy
5,557
+1,640
+42% +$94K ﹤0.01% 775
2014
Q4 		$209K Buy
+3,917
New +$219K ﹤0.01% 891
2014
Q2 		– Sell
-5,804
Closed -$387K – 895
2014
Q1 		$387K Buy
+5,804
New +$392K ﹤0.01% 815

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sterling Capital Management's GSK Position: Q4 2025 in Review

Sterling Capital Management sold out of GSK (GSK) in Q4 2025, closing a stake of 21,771 shares — an estimated $940K sold.

Sterling Capital Management first reported a position in GSK in Q1 2014 and held it in 26 quarters. The position peaked at $982K in Q1 2025. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Sterling Capital Management reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • Sterling Capital Management sold 21,771 GSK shares in Q4 2025, an estimated $940K.
  • Sterling Capital Management first reported a position in GSK in Q1 2014 and held it in 26 quarters.
  • Sterling Capital Management's GSK position peaked at $982K in Q1 2025.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Sterling Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.